speb/financial-data huggingface dataset:
Financial ratios for 8427.HK — annual report dated 2025-05-31
Total revenue: 7442216.981132075
Gross profit: 2213915.0943396227
Operating income: 312500
Net income: 19339.62264150943
Capital expenditures: 2848820.754716981
Operating cash flow: 1525943.396226415
Depreciation & amortization: 427830.18867924524
Net tangible assets: 7969103.773584905
Owner earnings: -2401650.9433962265
Return on net tangible assets (%): -30.137026843055438
Capex to operating income (%): 911.6226415094341
Buffett classification: The Gruesome
Stock price: 1.729591836734694
P/E ratio: 1462.3682038028874
Shares outstanding: 16351632
Book value: 8657547.169811321
P/B ratio: 3.2667046069477155
Market cap (USD): 28281649.2244898
Debt to equity: 0.19178380734444805
Current ratio: 2.7092186854071927
Quick ratio: 2.5657709797436956
Effective tax rate (%): 71.62241887905606
Interest coverage ratio: 9.265734265734265
COGS to revenue (%): 70.25194105530026
SG&A to revenue (%): 23.43844081762003
Free cash flow (dilution-adjusted): -1360377.358490566
Buyback yield (%): 0
Retained earnings: -1594575.471698113
Inventory turnover: 12.776945244956773
Receivables turnover: 5.864151644675711
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.076530138385808
FCF margin (%): -18.27919505625099
Revenue growth (%): 14.006778825073354
Rule of 40 score: -4.272416231177637
Financial ratios for 8427.HK — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 7969103.773584905
Buffett classification: The Gruesome
Stock price: 1.729591836734694
Shares outstanding: 16351632
Book value: 8657547.169811321
P/B ratio: 3.2667046069477155
Market cap (USD): 28281649.2244898
Debt to equity: 0.19178380734444805
Current ratio: 2.7092186854071927
Quick ratio: 2.5657709797436956
Buyback yield (%): 0
Retained earnings: -1594575.471698113
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8783.T — annual report dated 2022-03-31
Total revenue: 9807490.575315522
Gross profit: 5018972.299623013
Operating income: -5729364.038682183
Net income: -9508285.526962793
Capital expenditures: 1321406.326831667
Operating cash flow: -7910244.222258646
Depreciation & amortization: 526249.7951155548
Net tangible assets: 3227347.9757416816
Owner earnings: -10303442.058678905
Return on net tangible assets (%): -319.2541410509369
Buffett classification: The Gruesome
Stock price: 9.588592034092771
Shares outstanding: 41544528
Book value: 3742206.1957056224
P/B ratio: 106.4488457899716
Market cap (USD): 398353530.2409441
Debt to equity: 1.8206664564280457
Current ratio: 2.7444060968116024
Quick ratio: 2.1693556211623495
Interest coverage ratio: -52.524192336589024
COGS to revenue (%): 48.82502862013353
Free cash flow (dilution-adjusted): -9898328.14292739
Buyback yield (%): 0
Retained earnings: -13944959.842648746
Inventory turnover: 2.3472315399170043
Receivables turnover: 23.36365943655922
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.63600628331336
FCF margin (%): -100.92620601482398
Rule of 40 score: -100.92620601482398
Financial ratios for 8783.T — annual report dated 2023-03-31
Total revenue: 17667432.432432435
Gross profit: 7190930.930930931
Operating income: -14472117.117117118
Net income: -16924647.14714715
Capital expenditures: 229992.4924924925
Operating cash flow: -24885097.5975976
Depreciation & amortization: 868423.4234234235
Net tangible assets: 7052259.75975976
Owner earnings: -16286216.216216218
Return on net tangible assets (%): -230.93613637355608
Buffett classification: The Gruesome
Stock price: 8.258258258258259
Shares outstanding: 41544528
Book value: 9862545.045045048
P/B ratio: 34.7867046360217
Market cap (USD): 343085441.4414415
Debt to equity: 2.4477354263673874
Current ratio: 1.3322792957532628
Quick ratio: 1.1071682257180766
Interest coverage ratio: -16.12667525557582
COGS to revenue (%): 59.298339099699064
Free cash flow (dilution-adjusted): -25562537.53753754
Buyback yield (%): 0
Retained earnings: -21349376.87687688
Inventory turnover: 2.0461392285348556
Receivables turnover: 9.711867344580542
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.64971180350629
FCF margin (%): -144.68733719684087
Revenue growth (%): 80.14223207004252
Rule of 40 score: -64.54510512679835
Financial ratios for 8783.T — annual report dated 2024-03-31
Total revenue: 27566818.54199683
Gross profit: 12763635.763338616
Operating income: -14173824.617010036
Net income: -16238325.409403063
Capital expenditures: 148712.36133122028
Operating cash flow: -9720985.208663497
Depreciation & amortization: 1541970.4173269942
Net tangible assets: -871341.7855256207
Owner earnings: -14845067.35340729
Buffett classification: The Gruesome
Stock price: 3.895932382461701
Shares outstanding: 41544528
Book value: 1221071.0512414128
P/B ratio: 132.5513955840128
Market cap (USD): 161854671.94928685
Debt to equity: 18.86379982586975
Current ratio: 1.1918504137631343
Quick ratio: 1.032582783021244
Interest coverage ratio: -8.732253642025784
COGS to revenue (%): 53.699278921527416
Free cash flow (dilution-adjusted): -10494506.075013207
Buyback yield (%): 0
Retained earnings: -21809726.624405704
Inventory turnover: 4.8893769506415445
Receivables turnover: 7.41373560217792
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -131.3797702412962
FCF margin (%): -38.069340714908
Revenue growth (%): 56.03183228476315
Rule of 40 score: 17.962491569855146
Financial ratios for 8783.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2874870.4300322174
Buffett classification: The Gruesome
Stock price: 1.7859644207872252
Shares outstanding: 41544528
Book value: 4948536.20955316
P/B ratio: 14.993736681801195
Market cap (USD): 74197048.88639866
Debt to equity: 3.3699600312503533
Current ratio: 1.2743075711087155
Quick ratio: 1.149331457291505
Buyback yield (%): 0
Retained earnings: -28430823.644768175
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8TI.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.84090909090909
Shares outstanding: 2897507765
Market cap (USD): 40104141565.56818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8TI.DE — annual report dated 2022-12-31
Total revenue: 191055319148.9362
Gross profit: 37515957446.80851
Operating income: 22429787234.042553
Net income: 17871276595.744682
Capital expenditures: 9009574468.085108
Operating cash flow: 21232978723.404255
Depreciation & amortization: 7230851063.829787
Net tangible assets: 22611702127.659576
Owner earnings: 16092553191.489363
Return on net tangible assets (%): 71.16913667372383
Capex to operating income (%): 40.16789982925442
Buffett classification: The Good
Stock price: 11.170212765957448
P/E ratio: 1.8110501537293888
Shares outstanding: 2897507765
Book value: 77002127659.57446
P/B ratio: 0.4203231678110581
Market cap (USD): 32365778226.06383
Debt to equity: 0.3751347019977343
Current ratio: 1.268627010849233
Quick ratio: 1.0129592218481107
Effective tax rate (%): 13.98913266352266
Interest coverage ratio: 17.792405063291138
COGS to revenue (%): 80.36382466925029
R&D to revenue (%): 2.8954519132255334
SG&A to revenue (%): 5.0007795447458685
Free cash flow (dilution-adjusted): 11643617021.276596
Buyback yield (%): 3.0338059130192496
Retained earnings: 71045744680.85107
Inventory turnover: 8.44758560140474
Receivables turnover: 15.124810510358769
Capitalized R&D asset: 5531914893.617022
ROCI (R&D-adjusted, %): 19.714502145382813
FCF margin (%): 6.094369459664127
Rule of 40 score: 6.094369459664127
Financial ratios for 8TI.DE — annual report dated 2023-12-31
Total revenue: 210604444444.44443
Gross profit: 42382222222.22222
Operating income: 25537777777.77778
Net income: 20694444444.444443
Capital expenditures: 9546666666.666666
Operating cash flow: 19948888888.88889
Depreciation & amortization: 8387777777.777778
Net tangible assets: 33415555555.555553
Owner earnings: 19535555555.555557
Return on net tangible assets (%): 58.462459267141064
Capex to operating income (%): 37.38252697528715
Buffett classification: The Good
Stock price: 20.266666666666666
P/E ratio: 2.8376129736161078
Shares outstanding: 2897507765
Book value: 91244444444.44444
P/B ratio: 0.6435769804383829
Market cap (USD): 58722824037.33333
Debt to equity: 0.3587798343886994
Current ratio: 1.2377603462266702
Quick ratio: 0.951041384906681
Effective tax rate (%): 16.919439735926485
Interest coverage ratio: 17.281203007518798
COGS to revenue (%): 79.87591271683621
R&D to revenue (%): 2.964483180686279
SG&A to revenue (%): 5.033659730722154
Free cash flow (dilution-adjusted): 8623333333.333334
Buyback yield (%): 4.605440029118968
Retained earnings: 89917777777.77777
Inventory turnover: 7.141509433962265
Receivables turnover: 10.378579641898922
Capitalized R&D asset: 9949716312.056738
ROCI (R&D-adjusted, %): 18.280533607707085
Rosenberg metric: 0.8796709401709402
FCF margin (%): 4.0945637952137774
Revenue growth (%): 10.232180597007519
Rule of 40 score: 14.326744392221297
Financial ratios for 8TI.DE — annual report dated 2024-12-31
Total revenue: 163414583333.33334
Gross profit: 21372916666.666668
Operating income: 5661458333.333334
Net income: 5750000000
Capital expenditures: 10908333333.333334
Operating cash flow: 1598958333.3333335
Depreciation & amortization: 7527083333.333334
Net tangible assets: 28465625000
Owner earnings: 2368750000
Return on net tangible assets (%): 8.321440333735866
Capex to operating income (%): 192.67709291628336
Buffett classification: The Gruesome
Stock price: 12.125000000000002
P/E ratio: 6.109962026195653
Shares outstanding: 2897507765
Book value: 85536458333.33334
P/B ratio: 0.41072873877610666
Market cap (USD): 35132281650.62501
Debt to equity: 0.4533520063325823
Current ratio: 1.0850158274146784
Quick ratio: 0.8075572580001597
Effective tax rate (%): -36.904761904761905
Interest coverage ratio: 3.5686145764937622
COGS to revenue (%): 86.92104692818624
R&D to revenue (%): 3.686941444944479
SG&A to revenue (%): 5.927536047119418
Free cash flow (dilution-adjusted): -9921875000
Buyback yield (%): 8.894953168930906
Retained earnings: 80537500000
Inventory turnover: 6.536599396002109
Receivables turnover: 8.472106712750445
Capitalized R&D asset: 12033565248.226952
ROCI (R&D-adjusted, %): 3.8360748382017187
Rosenberg metric: -3.3650783057483538
FCF margin (%): -6.071597037188133
Revenue growth (%): -22.406868589878854
Rule of 40 score: -28.47846562706699
Financial ratios for 8TI.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 28465625000
Buffett classification: The Gruesome
Stock price: 12.125000000000002
Shares outstanding: 2897507765
Book value: 85536458333.33334
P/B ratio: 0.41072873877610666
Market cap (USD): 35132281650.62501
Debt to equity: 0.4533520063325823
Current ratio: 1.0850158274146784
Quick ratio: 0.8075572580001597
Buyback yield (%): 0
Retained earnings: 80537500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8TI.DE — quarterly report dated 2025-03-31
Total revenue: 38927173913.04348
Gross profit: 3940217391.3043475
Operating income: -167391304.3478261
Net income: -403260869.5652174
Capital expenditures: 2745652173.9130435
Operating cash flow: -3093478260.869565
Depreciation & amortization: 2042391304.347826
Owner earnings: -1106521739.130435
Buffett classification: The Gruesome
Stock price: 10.239130434782608
Shares outstanding: 2897507765
Market cap (USD): 29667959941.630432
Interest coverage ratio: -0.4301675977653632
COGS to revenue (%): 89.87797727082344
R&D to revenue (%): 4.001340295423449
SG&A to revenue (%): 6.550693882109848
Free cash flow (dilution-adjusted): -5981521739.130435
Buyback yield (%): 0
Capitalized R&D asset: 1557608695.6521738
ROCI (R&D-adjusted, %): 55.91998139102118
FCF margin (%): -15.365928573423057
Rule of 40 score: -15.365928573423057
Financial ratios for 8TI.DE — quarterly report dated 2025-06-30
Total revenue: 45232941176.47059
Gross profit: 2787058823.529412
Operating income: -1643529411.764706
Net income: -2198823529.4117646
Capital expenditures: 2920000000
Operating cash flow: 657647058.8235295
Depreciation & amortization: 2003529411.764706
Net tangible assets: 27447058823.52941
Owner earnings: -3115294117.6470585
Return on net tangible assets (%): -11.350192884697814
Buffett classification: The Gruesome
Stock price: 10.023529411764706
Shares outstanding: 2897507765
Book value: 86497647058.82355
P/B ratio: 0.3357692988289378
Market cap (USD): 29043254303.294117
Debt to equity: 0.5549147885695631
Current ratio: 1.0607825055987352
Quick ratio: 0.7734422342247398
Interest coverage ratio: -4.207831325301205
COGS to revenue (%): 93.83843112775698
R&D to revenue (%): 5.040574282147316
SG&A to revenue (%): 4.754473574698294
Free cash flow (dilution-adjusted): -2284705882.352941
Buyback yield (%): 0
Retained earnings: 86135294117.64706
Inventory turnover: 1.6540894920227396
Receivables turnover: 1.846952010376135
Capitalized R&D asset: 3323597826.0869565
ROCI (R&D-adjusted, %): -0.42815556139652305
Rosenberg metric: -0.7403390665407823
FCF margin (%): -5.0509779442363705
Revenue growth (%): 16.19888275864334
Rule of 40 score: 11.147904814406969
Financial ratios for 8TI.DE — annual report dated 2025-12-31
Total revenue: 180597647058.82355
Gross profit: -2492941176.470588
Operating income: -26154117647.058823
Net income: -26272941176.47059
Capital expenditures: 10485882352.941177
Operating cash flow: -5470588235.294118
Depreciation & amortization: 8212941176.470589
Net tangible assets: 10195294117.647058
Owner earnings: -28545882352.941177
Return on net tangible assets (%): -279.9907685206555
Buffett classification: The Gruesome
Stock price: 11.117647058823529
Shares outstanding: 2897507765
Book value: 63530588235.29413
P/B ratio: 0.5070544689774262
Market cap (USD): 32213468681.47059
Debt to equity: 0.850854613803448
Current ratio: 1.0228476358602472
Quick ratio: 0.7415004000558808
Interest coverage ratio: -15.061653116531165
COGS to revenue (%): 101.3803840842171
R&D to revenue (%): 7.2602079370456245
SG&A to revenue (%): 5.841389373843708
Free cash flow (dilution-adjusted): -16225882352.941177
Buyback yield (%): 0
Retained earnings: 62667058823.52941
Inventory turnover: 7.025098180833296
Receivables turnover: 7.038745472052823
Capitalized R&D asset: 19208814705.882355
ROCI (R&D-adjusted, %): -13.768888260600038
Rosenberg metric: -3.9611382312261005
FCF margin (%): -8.984548036584412
Revenue growth (%): 10.515012415042643
Rule of 40 score: 1.5304643784582304
Financial ratios for 8TI.DE — quarterly report dated 2025-12-31
Total revenue: 49421176470.588234
Capital expenditures: 0
Net tangible assets: 10195294117.647058
Buffett classification: The Gruesome
Stock price: 11.117647058823529
Shares outstanding: 2897507765
Book value: 63530588235.29413
P/B ratio: 0.5070544689774262
Market cap (USD): 32213468681.47059
Debt to equity: 0.850854613803448
Current ratio: 1.0228476358602472
Quick ratio: 0.7415004000558808
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 62667058823.52941
Inventory turnover: 0
Receivables turnover: 1.9261772662662204
Capitalized R&D asset: 2041610869.5652175
Revenue growth (%): 9.259259259259254
Rule of 40 score: 9.259259259259254
Financial ratios for AEIS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 30833000
Buffett classification: The Gruesome
Stock price: 89.64
Shares outstanding: 40010657
Market cap (USD): 3586555293.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIS — annual report dated 2022-12-31
Total revenue: 1845422000
Gross profit: 675506000
Operating income: 239909000
Net income: 199676000
Capital expenditures: 58885000
Operating cash flow: 183587000
Depreciation & amortization: 60296000
Net tangible assets: 595308000
Owner earnings: 201087000
Return on net tangible assets (%): 33.77864903545728
Capex to operating income (%): 24.54472320754953
Buffett classification: The Great
Stock price: 84.83
P/E ratio: 16.99805701892065
Shares outstanding: 40010657
Book value: 1066267000
P/B ratio: 3.1831652234477854
Market cap (USD): 3394104033.31
Debt to equity: 0.45438243892008284
Current ratio: 3.0238777945415642
Quick ratio: 2.0672089313383015
Effective tax rate (%): 16.484584741520884
Interest coverage ratio: 32.7520819112628
COGS to revenue (%): 63.39558106492716
R&D to revenue (%): 10.351019983505127
SG&A to revenue (%): 11.838105322251497
Free cash flow (dilution-adjusted): 104853000
Buyback yield (%): 0.7847431822537567
Retained earnings: 915270000
Inventory turnover: 3.1113794240609343
Receivables turnover: 6.1374337757704955
Capitalized R&D asset: 191020000
ROCI (R&D-adjusted, %): 20.51541448690842
FCF margin (%): 5.681789856195493
Rule of 40 score: 5.681789856195493
Financial ratios for AEIS — annual report dated 2023-12-31
Total revenue: 1655800000
Gross profit: 592400000
Operating income: 140700000
Net income: 128300000
Capital expenditures: 61000000
Operating cash flow: 208900000
Depreciation & amortization: 66500000
Net tangible assets: 698864000
Owner earnings: 133800000
Return on net tangible assets (%): 19.14535589184734
Capex to operating income (%): 43.3546552949538
Buffett classification: The Good
Stock price: 108.15
P/E ratio: 33.72683206975838
Shares outstanding: 40010657
Book value: 1144182000
P/B ratio: 3.7818743473940333
Market cap (USD): 4327152554.55
Debt to equity: 0.8938726531268627
Current ratio: 5.0972285081346325
Quick ratio: 4.096367999809438
Effective tax rate (%): -6.775510204081632
Interest coverage ratio: 9.256578947368421
COGS to revenue (%): 64.22273221403552
R&D to revenue (%): 12.223698514313323
SG&A to revenue (%): 13.347022587268995
Free cash flow (dilution-adjusted): 116900000
Buyback yield (%): 0.9243954192911458
Retained earnings: 989731000
Inventory turnover: 3.163591035797904
Receivables turnover: 5.862691640406473
Capitalized R&D asset: 330383400
ROCI (R&D-adjusted, %): 8.307946200129786
Rosenberg metric: -0.435064391163229
FCF margin (%): 7.060031404759029
Revenue growth (%): -10.275264952948431
Rule of 40 score: -3.215233548189402
Financial ratios for AEIS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 104.79
Shares outstanding: 40010657
Market cap (USD): 4192716747.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIS — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 11104000
Buffett classification: The Gruesome
Stock price: 115.23
Shares outstanding: 40010657
Market cap (USD): 4610428006.110001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AEIS — annual report dated 2024-12-31
Total revenue: 1482000000
Gross profit: 529300000
Operating income: 66900000
Net income: 54200000
Capital expenditures: 56800000
Operating cash flow: 130800000
Depreciation & amortization: 68500000
Net tangible assets: 767700000
Owner earnings: 65900000
Return on net tangible assets (%): 8.58408232382441
Capex to operating income (%): 84.90284005979073
Buffett classification: The Gruesome
Stock price: 115.23
P/E ratio: 85.06324734520295
Shares outstanding: 40010657
Book value: 1203100000
P/B ratio: 3.8321236855706093
Market cap (USD): 4610428006.110001
Debt to equity: 0.5583077050951708
Current ratio: 4.4202990773146675
Quick ratio: 3.2736239261851736
Effective tax rate (%): -7.442748091603053
Interest coverage ratio: 3.040909090909091
COGS to revenue (%): 64.28475033738191
R&D to revenue (%): 14.291497975708504
SG&A to revenue (%): 15.155195681511472
Free cash flow (dilution-adjusted): 28100000
Buyback yield (%): 0.03904192837659622
Retained earnings: 1026700000
Inventory turnover: 2.643451720310766
Receivables turnover: 5.58612891066717
Capitalized R&D asset: 410444600
ROCI (R&D-adjusted, %): 3.263721135724065
Rosenberg metric: -0.3117588932806324
FCF margin (%): 1.8960863697705803
Revenue growth (%): -10.496436767725571
Rule of 40 score: -8.60035039795499
Financial ratios for AEIS — quarterly report dated 2025-03-31
Total revenue: 404600000
Gross profit: 150500000
Operating income: 31800000
Net income: 24700000
Capital expenditures: 13900000
Operating cash flow: 28900000
Depreciation & amortization: 16100000
Net tangible assets: 799000000
Owner earnings: 26900000
Return on net tangible assets (%): 3.3667083854818523
Capex to operating income (%): 43.710691823899374
Buffett classification: The Good
Stock price: 95.06
P/E ratio: 38.496083546761135
Shares outstanding: 40010657
Book value: 1230300000
P/B ratio: 3.091451722685524
Market cap (USD): 3803413054.42
Debt to equity: 0.5537673738112655
Current ratio: 4.430451127819549
Quick ratio: 3.275062656641604
Effective tax rate (%): 16.722408026755854
Interest coverage ratio: 9.085714285714285
COGS to revenue (%): 62.80276816608996
R&D to revenue (%): 13.395946613939694
SG&A to revenue (%): 14.58230350963915
Free cash flow (dilution-adjusted): 2000000
Buyback yield (%): 0.013146087286495032
Retained earnings: 1046900000
Inventory turnover: 0.6889913232104121
Receivables turnover: 1.4622334658474883
Capitalized R&D asset: 54200000
ROCI (R&D-adjusted, %): 3.3346423195235286
FCF margin (%): 0.4943153732081068
Rule of 40 score: 0.4943153732081068
Financial ratios for AEIS — quarterly report dated 2025-06-30
Total revenue: 441500000
Gross profit: 163400000
Operating income: 38600000
Net income: 25200000
Capital expenditures: 28100000
Operating cash flow: 45200000
Depreciation & amortization: 15600000
Net tangible assets: 827700000
Owner earnings: 12700000
Return on net tangible assets (%): 1.5343723571342274
Capex to operating income (%): 72.7979274611399
Buffett classification: The Good
Stock price: 132.27
P/E ratio: 106.05630463707416
Shares outstanding: 40010657
Book value: 1257300000
P/B ratio: 4.20918603466953
Market cap (USD): 5292209601.39
Debt to equity: 0.5468066491688539
Current ratio: 4.089380778929672
Quick ratio: 2.974502661810031
Effective tax rate (%): 12.969283276450511
Interest coverage ratio: 11.352941176470589
COGS to revenue (%): 62.98980747451869
R&D to revenue (%): 13.363533408833522
SG&A to revenue (%): 13.635334088335222
Free cash flow (dilution-adjusted): 3500000
Buyback yield (%): 0.4383802182344878
Retained earnings: 1045900000
Inventory turnover: 0.6989193264639356
Receivables turnover: 1.4523026315789473
Capitalized R&D asset: 95314000
ROCI (R&D-adjusted, %): 2.826547259209177
Rosenberg metric: 0.23800738007380073
FCF margin (%): 0.7927519818799547
Revenue growth (%): 9.12011863568957
Rule of 40 score: 9.912870617569524
Financial ratios for AEIS — quarterly report dated 2025-09-30
Total revenue: 463300000
Gross profit: 174400000
Operating income: 49900000
Net income: 46200000
Capital expenditures: 27900000
Operating cash flow: 78700000
Depreciation & amortization: 15100000
Net tangible assets: 883400000
Owner earnings: 33400000
Return on net tangible assets (%): 3.780846728548789
Capex to operating income (%): 55.91182364729459
Buffett classification: The Good
Stock price: 169.95
P/E ratio: 70.75766032414153
Shares outstanding: 40010657
Book value: 1307200000
P/B ratio: 5.201813920708385
Market cap (USD): 6799811157.15
Debt to equity: 0.5223378212974297
Current ratio: 4.100136425648022
Quick ratio: 3.009549795361528
Effective tax rate (%): 11.281070745697896
Interest coverage ratio: 14.676470588235293
COGS to revenue (%): 62.357004101014454
R&D to revenue (%): 12.756313403842004
SG&A to revenue (%): 12.90740341031729
Free cash flow (dilution-adjusted): 36200000
Buyback yield (%): 0
Retained earnings: 1087300000
Inventory turnover: 0.7227920940705529
Receivables turnover: 1.5469115191986644
Capitalized R&D asset: 116516000
ROCI (R&D-adjusted, %): 2.35666969514718
Rosenberg metric: 0.1864406779661017
FCF margin (%): 7.8135117634362174
Revenue growth (%): 4.93771234428086
Rule of 40 score: 12.751224107717078
Financial ratios for AEIS — quarterly report dated 2025-12-31
Total revenue: 489400000
Gross profit: 189100000
Operating income: 60200000
Net income: 52300000
Capital expenditures: 37500000
Operating cash flow: 80500000
Depreciation & amortization: 15200000
Net tangible assets: 944300000
Owner earnings: 30000000
Return on net tangible assets (%): 3.1769564756962834
Capex to operating income (%): 62.292358803986716
Buffett classification: The Good
Stock price: 209.24
P/E ratio: 56.41394791563343
Shares outstanding: 40010657
Book value: 1362800000
P/B ratio: 6.14310967910185
Market cap (USD): 8371829870.68
Debt to equity: 0.4982389198708541
Current ratio: 1.5878732849071833
Quick ratio: 1.1730225988700564
Effective tax rate (%): 8.216783216783217
Interest coverage ratio: 18.242424242424242
COGS to revenue (%): 61.36085002043319
R&D to revenue (%): 12.280343277482633
SG&A to revenue (%): 12.954638332652227
Free cash flow (dilution-adjusted): 28500000
Buyback yield (%): 0.07764132931994279
Retained earnings: 1128600000
Inventory turnover: 0.7303015564202334
Receivables turnover: 1.504920049200492
Capitalized R&D asset: 119167000
ROCI (R&D-adjusted, %): 3.638499265429418
Rosenberg metric: 0.24873096446700507
FCF margin (%): 5.823457294646506
Revenue growth (%): 5.633498812864235
Rule of 40 score: 11.456956107510742
Financial ratios for AEIS — annual report dated 2025-12-31
Total revenue: 1798800000
Gross profit: 677400000
Operating income: 180500000
Net income: 148400000
Capital expenditures: 107400000
Operating cash flow: 233300000
Depreciation & amortization: 62000000
Net tangible assets: 944300000
Owner earnings: 103000000
Return on net tangible assets (%): 10.907550566557237
Capex to operating income (%): 59.501385041551245
Buffett classification: The Good
Stock price: 209.24
P/E ratio: 56.41394791563343
Shares outstanding: 40010657
Book value: 1362800000
P/B ratio: 6.14310967910185
Market cap (USD): 8371829870.68
Debt to equity: 0.4982389198708541
Current ratio: 1.5878732849071833
Quick ratio: 1.1730225988700564
Effective tax rate (%): 11.499703615886189
Interest coverage ratio: 13.272058823529411
COGS to revenue (%): 62.34156104069379
R&D to revenue (%): 12.91972426061819
SG&A to revenue (%): 13.475650433622416
Free cash flow (dilution-adjusted): 70200000
Buyback yield (%): 0.36073356084034963
Retained earnings: 1128600000
Inventory turnover: 2.7271400778210118
Receivables turnover: 5.531365313653136
Capitalized R&D asset: 441098000
ROCI (R&D-adjusted, %): 9.889605875571688
Rosenberg metric: 0.6992445703493863
FCF margin (%): 3.90260173448966
Revenue growth (%): 21.376518218623485
Rule of 40 score: 25.279119953113145
Financial ratios for AIXC — annual report dated 2021-12-31
Gross profit: 1321240
Capital expenditures: 134471
Depreciation & amortization: 338277
Buffett classification: The Gruesome
Stock price: 535
Shares outstanding: 20234993
Market cap (USD): 10825721255
Buyback yield (%): 0
Inventory turnover: 4.103206052214365
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIXC — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 680801
Operating income: -14760720
Net income: -18640543
Capital expenditures: 319117
Operating cash flow: -13247541
Depreciation & amortization: 375603
Net tangible assets: 7235709
Owner earnings: -18584057
Return on net tangible assets (%): -256.83809285309843
Buffett classification: The Gruesome
Stock price: 64.45
Shares outstanding: 20234993
Book value: 8766590
P/B ratio: 148.76312213186657
Market cap (USD): 1304145298.8500001
Debt to equity: 0.14850916947182427
Current ratio: 1.2570080815095521
Quick ratio: 1.072729984738915
Interest coverage ratio: -429.128121638515
Free cash flow (dilution-adjusted): -18012817
Buyback yield (%): 3.872267917120207e-05
Retained earnings: -103385172
Inventory turnover: 2.7124523339576383
Receivables turnover: 0
Capitalized R&D asset: 4486120
ROCI (R&D-adjusted, %): -78.66870942876585
Rule of 40 score: 0
Financial ratios for AIXC — annual report dated 2023-12-31
Total revenue: 0
Operating income: -11304857
Net income: -13417212
Capital expenditures: 0
Operating cash flow: -10304263
Depreciation & amortization: 4495
Net tangible assets: -2103557
Owner earnings: -13412717
Buffett classification: The Gruesome
Stock price: 27.5
Shares outstanding: 20234993
Book value: -2103557
Market cap (USD): 556462307.5
Debt to equity: -0.617628141286402
Current ratio: 0.28204544328292
Quick ratio: 0.28204544328292
Interest coverage ratio: -7.414372587265088
Free cash flow (dilution-adjusted): -11402796
Buyback yield (%): 0
Retained earnings: -116802384
Capitalized R&D asset: 8214950.4
ROCI (R&D-adjusted, %): -152.6230826508403
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.55
Shares outstanding: 20234993
Market cap (USD): 173009190.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIXC — annual report dated 2024-12-31
Total revenue: 0
Operating income: -5761720
Net income: -6259191
Capital expenditures: 0
Operating cash flow: -6327503
Depreciation & amortization: 0
Net tangible assets: 2679036
Owner earnings: -6259191
Return on net tangible assets (%): -233.6359421821879
Buffett classification: The Gruesome
Stock price: 4.21
Shares outstanding: 20234993
Book value: 2679036
P/B ratio: 31.798497866396715
Market cap (USD): 85189320.53
Debt to equity: 0
Current ratio: 2.333528602732875
Quick ratio: 2.333528602732875
Interest coverage ratio: -6.338923342827878
Free cash flow (dilution-adjusted): -6455562
Buyback yield (%): 0
Retained earnings: -123061575
Receivables turnover: 0
Capitalized R&D asset: 6167779.1
ROCI (R&D-adjusted, %): -92.63675014525849
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.21
Shares outstanding: 20234993
Market cap (USD): 85189320.53
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2724699
Net income: -2646172
Capital expenditures: 0
Operating cash flow: -1589396
Net tangible assets: 33134
Owner earnings: -2646172
Return on net tangible assets (%): -7986.273918029818
Buffett classification: The Gruesome
Stock price: 3.64
Shares outstanding: 20234993
Book value: 33134
P/B ratio: 2222.954503531116
Market cap (USD): 73655374.52
Debt to equity: 25.460705015995654
Current ratio: 1.011062377682806
Quick ratio: 1.011062377682806
Interest coverage ratio: -37.01282347347687
Free cash flow (dilution-adjusted): -1589665
Buyback yield (%): 0
Retained earnings: -125707745
Receivables turnover: 0
Capitalized R&D asset: 33167
ROCI (R&D-adjusted, %): -4076.2396746152644
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1683747
Net income: -1685417
Capital expenditures: 0
Operating cash flow: -1098111
Net tangible assets: -1652283
Owner earnings: -1685417
Buffett classification: The Gruesome
Stock price: 3.41
Shares outstanding: 20234993
Book value: -1652283
Market cap (USD): 69001326.13000001
Debt to equity: -2.18893252548141
Current ratio: 0.7053791694894849
Quick ratio: 0.7053791694894849
Interest coverage ratio: -15.876617131218648
Free cash flow (dilution-adjusted): -1098111
Buyback yield (%): 0
Retained earnings: -127393162
Receivables turnover: 0
Capitalized R&D asset: 40036.89
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1429684
Net income: -2037819
Capital expenditures: 0
Operating cash flow: -2141478
Net tangible assets: 38547078
Owner earnings: -2037819
Return on net tangible assets (%): -5.286571916034725
Buffett classification: The Gruesome
Stock price: 5.72
Shares outstanding: 20234993
Book value: 38547078
P/B ratio: 3.0026701365016564
Market cap (USD): 115744159.96
Debt to equity: 0.08397116378055945
Current ratio: 8.829136475110323
Quick ratio: 8.829136475110323
Interest coverage ratio: -3.1356776425019905
Free cash flow (dilution-adjusted): -2141478
Buyback yield (%): 0
Retained earnings: -129430981
Receivables turnover: 0
Capitalized R&D asset: 128457.16
ROCI (R&D-adjusted, %): -3.558564850638256
Rule of 40 score: 0
Financial ratios for AIXC — annual report dated 2025-12-31
Total revenue: 0
Operating income: -13202096
Net income: -16965875
Capital expenditures: 16593416
Operating cash flow: -6951458
Net tangible assets: 27635882
Owner earnings: -33559291
Return on net tangible assets (%): -121.43376136864386
Buffett classification: The Gruesome
Stock price: 2.34
Shares outstanding: 20234993
Book value: 27950609
P/B ratio: 1.6940555255880112
Market cap (USD): 47349883.62
Debt to equity: 0.005088833663695843
Current ratio: 9.29785713663521
Quick ratio: 9.29785713663521
Interest coverage ratio: -13.355686393525543
Free cash flow (dilution-adjusted): -23545142
Buyback yield (%): 0
Retained earnings: -140027450
Receivables turnover: 0
Capitalized R&D asset: 2705947.04
ROCI (R&D-adjusted, %): -49.62843612792631
Rule of 40 score: 0
Financial ratios for AIXC — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -7363966
Net income: -10596468
Capital expenditures: 0
Operating cash flow: -2122473
Net tangible assets: 27635882
Owner earnings: -10596468
Return on net tangible assets (%): -38.34315112504822
Buffett classification: The Gruesome
Stock price: 2.34
Shares outstanding: 20234993
Book value: 27950609
P/B ratio: 1.6940555255880112
Market cap (USD): 47349883.62
Debt to equity: 0.005088833663695843
Current ratio: 9.29785713663521
Quick ratio: 9.29785713663521
Interest coverage ratio: -20.867418735990796
Free cash flow (dilution-adjusted): -18715888
Buyback yield (%): 0
Retained earnings: -140027450
Receivables turnover: 0
Capitalized R&D asset: 104852.87
ROCI (R&D-adjusted, %): -26.327390488973617
Rule of 40 score: 0
Financial ratios for ALESA.PA — annual report dated 2021-12-31
Capital expenditures: 3875000
Depreciation & amortization: 2034090.9090909092
Buffett classification: The Gruesome
Stock price: 9.818181818181818
Shares outstanding: 5213165
Market cap (USD): 51183801.81818182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALESA.PA — annual report dated 2022-12-31
Total revenue: 15944680.85106383
Gross profit: 1365957.4468085107
Operating income: -5891489.361702128
Net income: -1907446.8085106383
Capital expenditures: 1022340.4255319149
Operating cash flow: 3038297.872340426
Depreciation & amortization: 2517021.276595745
Net tangible assets: 15494680.85106383
Owner earnings: -412765.95744680846
Return on net tangible assets (%): -2.6639203570202534
Buffett classification: The Gruesome
Stock price: 8.191489361702128
Shares outstanding: 5213165
Book value: 16600000
P/B ratio: 2.572505158933607
Market cap (USD): 42703585.63829788
Debt to equity: 1.8720199948731095
Current ratio: 3.2566759665205263
Quick ratio: 2.9948186528497414
Interest coverage ratio: -4.123603871928519
COGS to revenue (%): 91.43314651721377
Free cash flow (dilution-adjusted): 2015957.4468085107
Buyback yield (%): 0
Retained earnings: -1907446.8085106383
Inventory turnover: 10.429223744292237
Receivables turnover: 3.701654729562855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.934058829867473
FCF margin (%): 12.643448091806778
Rule of 40 score: 12.643448091806778
Financial ratios for ALESA.PA — annual report dated 2023-12-31
Total revenue: 11405555.555555556
Gross profit: 3260000
Operating income: -1777777.7777777778
Net income: -8170000
Capital expenditures: 445555.55555555556
Operating cash flow: -1146666.6666666667
Depreciation & amortization: 1416666.6666666667
Net tangible assets: 8183333.333333333
Owner earnings: -7198888.888888889
Return on net tangible assets (%): -87.97012898845892
Buffett classification: The Gruesome
Stock price: 1.4333333333333333
Shares outstanding: 5213165
Book value: 8288888.888888892
P/B ratio: 0.901472231903485
Market cap (USD): 7472203.166666667
Debt to equity: 2.7621983914209105
Current ratio: 7.562903225806452
Quick ratio: 6.908064516129032
Interest coverage ratio: -1.1958146487294468
COGS to revenue (%): 71.41743789576229
Free cash flow (dilution-adjusted): -1592222.2222222222
Buyback yield (%): 0
Retained earnings: -8170000
Inventory turnover: 4.514162561576354
Receivables turnover: 6.278287461773701
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.065214638470304
FCF margin (%): -13.960058451047248
Revenue growth (%): -28.46795955282745
Rule of 40 score: -42.4280180038747
Financial ratios for ALESA.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4589583.333333334
Buffett classification: The Gruesome
Stock price: 0.6875000000000001
Shares outstanding: 5213165
Book value: 5247916.666666668
P/B ratio: 0.6829473799126636
Market cap (USD): 3584050.9375000005
Debt to equity: 3.5275903136165137
Current ratio: 9.393180236604037
Quick ratio: 7.721642310368824
Buyback yield (%): 0
Retained earnings: -3231250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALESA.PA — annual report dated 2024-12-31
Total revenue: 11983333.333333334
Gross profit: 8037500
Operating income: -1000000
Net income: -3231250
Capital expenditures: 0
Operating cash flow: -685416.6666666667
Depreciation & amortization: 1480208.3333333335
Net tangible assets: 4589583.333333334
Owner earnings: -1751041.6666666665
Return on net tangible assets (%): -38.15251929187471
Buffett classification: The Gruesome
Stock price: 0.6875000000000001
Shares outstanding: 5213165
Book value: 5247916.666666668
P/B ratio: 0.6829473799126636
Market cap (USD): 3584050.9375000005
Debt to equity: 3.5275903136165137
Current ratio: 9.393180236604037
Quick ratio: 7.721642310368824
Interest coverage ratio: -1.6842105263157894
COGS to revenue (%): 32.92767732962448
Free cash flow (dilution-adjusted): -685416.6666666667
Buyback yield (%): 0
Retained earnings: -3231250
Inventory turnover: 1.5770191507077436
Receivables turnover: 9.683501683501683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.7777427986777896
FCF margin (%): -5.719749652294855
Revenue growth (%): 5.065757428153923
Rule of 40 score: -0.6539922241409322
Financial ratios for ALESA.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4097647.0588235296
Buffett classification: The Gruesome
Stock price: 0.8588235294117647
Shares outstanding: 5213165
Book value: 4702352.94117647
P/B ratio: 0.9521167000250187
Market cap (USD): 4477188.764705882
Debt to equity: 0
Current ratio: 6.499390243902439
Quick ratio: 5.842682926829268
Buyback yield (%): 0
Retained earnings: -1165882.3529411764
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALFEN.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 100.2840909090909
Shares outstanding: 21742981
Market cap (USD): 2180475083.2386365
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALFEN.AS — annual report dated 2022-12-31
Total revenue: 467953191.4893617
Gross profit: 163310638.29787236
Operating income: 72669148.93617022
Net income: 56432978.72340426
Capital expenditures: 12188297.872340426
Operating cash flow: 456382.9787234043
Depreciation & amortization: 10806382.978723405
Net tangible assets: 135159574.4680851
Owner earnings: 55051063.82978724
Return on net tangible assets (%): 40.73042109405746
Capex to operating income (%): 16.772314043537452
Buffett classification: The Great
Stock price: 89.57446808510639
P/E ratio: 34.51201764850039
Shares outstanding: 21742981
Book value: 160194680.85106388
P/B ratio: 12.157806659450268
Market cap (USD): 1947615957.6595745
Debt to equity: 0.12221831149598557
Current ratio: 1.7273235950470347
Quick ratio: 0.8596001553561672
Effective tax rate (%): 20.556212840519375
Interest coverage ratio: 69.98872950819673
COGS to revenue (%): 65.10107393901919
R&D to revenue (%): 0.18868953977939237
SG&A to revenue (%): 3.14315852649383
Free cash flow (dilution-adjusted): -22969148.936170213
Buyback yield (%): 0.002294130466949049
Retained earnings: 103996808.5106383
Inventory turnover: 2.1724689906308083
Receivables turnover: 6.167811772624022
Capitalized R&D asset: 882978.7234042553
ROCI (R&D-adjusted, %): 40.50844632685275
FCF margin (%): -4.908428739008266
Rule of 40 score: -4.908428739008266
Financial ratios for ALFEN.AS — annual report dated 2023-12-31
Total revenue: 560530000
Gross profit: 167876666.66666666
Operating income: 46592222.222222224
Net income: 32982222.22222222
Capital expenditures: 26657777.777777776
Operating cash flow: 6263333.333333333
Depreciation & amortization: 15728888.888888888
Net tangible assets: 167768888.8888889
Owner earnings: 22053333.33333333
Return on net tangible assets (%): 13.145067288333154
Capex to operating income (%): 57.21508120096344
Buffett classification: The Good
Stock price: 66.97777777777777
P/E ratio: 44.153985132731435
Shares outstanding: 21742981
Book value: 199569999.99999997
P/B ratio: 7.297171667306933
Market cap (USD): 1456296549.6444445
Debt to equity: 0.31830658137217244
Current ratio: 1.64916650498419
Quick ratio: 0.8585339506982059
Effective tax rate (%): 22.862637077075
Interest coverage ratio: 12.340494408475575
COGS to revenue (%): 70.05036899600972
R&D to revenue (%): 0.3589856425565487
SG&A to revenue (%): 3.4346461781211035
Free cash flow (dilution-adjusted): -33462222.222222224
Buyback yield (%): 0.1580111627451791
Retained earnings: 142772222.2222222
Inventory turnover: 2.3437947683981535
Receivables turnover: 6.371187532362562
Capitalized R&D asset: 2603817.9669030732
ROCI (R&D-adjusted, %): 20.65197059788736
Rosenberg metric: 5.171164658634499
FCF margin (%): -5.96974688637936
Revenue growth (%): 19.78334803444607
Rule of 40 score: 13.813601148066711
Financial ratios for ALFEN.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 130533333.33333334
Buffett classification: The Gruesome
Stock price: 12.53125
Shares outstanding: 21742981
Book value: 158578125.00000003
P/B ratio: 1.7181861032614048
Market cap (USD): 272466730.65625
Debt to equity: 0.3267908168292442
Current ratio: 1.67535677642011
Quick ratio: 0.9988940264101162
Buyback yield (%): 0
Retained earnings: 106191666.66666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALFEN.AS — annual report dated 2024-12-31
Total revenue: 507961458.3333334
Gross profit: 120192708.33333334
Operating income: -31754166.666666668
Net income: -28139583.333333336
Capital expenditures: 14369791.666666668
Operating cash flow: 58145833.333333336
Depreciation & amortization: 27363541.666666668
Net tangible assets: 130533333.33333334
Owner earnings: -15145833.333333336
Return on net tangible assets (%): -11.603038815117468
Buffett classification: The Gruesome
Stock price: 12.53125
Shares outstanding: 21742981
Book value: 158578125.00000003
P/B ratio: 1.7181861032614048
Market cap (USD): 272466730.65625
Debt to equity: 0.3267908168292442
Current ratio: 1.67535677642011
Quick ratio: 0.9988940264101162
Interest coverage ratio: -6.02212564203872
COGS to revenue (%): 76.3382228392492
R&D to revenue (%): 0.31129330268249517
SG&A to revenue (%): 4.731535159942827
Free cash flow (dilution-adjusted): 32073958.333333332
Buyback yield (%): 0.41060058866836097
Retained earnings: 106191666.66666667
Inventory turnover: 3.6663744792333524
Receivables turnover: 5.520882629320593
Capitalized R&D asset: 3220821.8676122935
ROCI (R&D-adjusted, %): -14.08980192329846
Rosenberg metric: -23.69716316951959
FCF margin (%): 6.314250383989926
Revenue growth (%): -9.378363632038718
Rule of 40 score: -3.064113248048792
Financial ratios for ALFEN.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 143130588.23529413
Buffett classification: The Gruesome
Stock price: 12.23529411764706
Shares outstanding: 21742981
Book value: 178037647.05882353
P/B ratio: 1.4942444585414851
Market cap (USD): 266031767.5294118
Debt to equity: 0.3245447096450189
Current ratio: 1.7508023771863819
Quick ratio: 1.085474285538783
Buyback yield (%): 0
Retained earnings: 118916470.5882353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.18
Shares outstanding: 433227989
Market cap (USD): 7442856851.0199995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APG — annual report dated 2022-12-31
Total revenue: 6558000000
Gross profit: 1714000000
Operating income: 162000000
Net income: 73000000
Capital expenditures: 62000000
Operating cash flow: 270000000
Depreciation & amortization: 304000000
Net tangible assets: -2039000000
Owner earnings: 315000000
Return on net tangible assets (%): -15.448749386954388
Capex to operating income (%): 38.2716049382716
Buffett classification: The Good
Stock price: 12.54
P/E ratio: 74.42026002821918
Shares outstanding: 433227989
Book value: 2127000000
P/B ratio: 2.554150908349788
Market cap (USD): 5432678982.059999
Debt to equity: 1.4236013164080865
Current ratio: 1.3805309734513274
Quick ratio: 1.295679333680375
Effective tax rate (%): 21.50537634408602
Interest coverage ratio: 1.296
COGS to revenue (%): 73.86398292162245
SG&A to revenue (%): 23.665751753583407
Free cash flow (dilution-adjusted): 173000000
Buyback yield (%): 0.8099134910289838
Retained earnings: -164000000
Inventory turnover: 29.717791411042946
Receivables turnover: 3.700902934537246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.625607779578606
FCF margin (%): 2.6379993900579444
Rule of 40 score: 2.6379993900579444
Financial ratios for APG — annual report dated 2023-12-31
Total revenue: 6928000000
Gross profit: 1940000000
Operating income: 359000000
Net income: 153000000
Capital expenditures: 32000000
Operating cash flow: 514000000
Depreciation & amortization: 303000000
Net tangible assets: -2020000000
Owner earnings: 424000000
Return on net tangible assets (%): -20.99009900990099
Capex to operating income (%): 8.913649025069638
Buffett classification: The Great
Stock price: 23.07
P/E ratio: 65.32398500803922
Shares outstanding: 433227989
Book value: 2071000000
P/B ratio: 4.825963160902946
Market cap (USD): 9994569706.23
Debt to equity: 1.2428778367938194
Current ratio: 1.4288876591034865
Quick ratio: 1.3458771444382955
Effective tax rate (%): 34.05172413793103
Interest coverage ratio: 2.475862068965517
COGS to revenue (%): 71.99769053117782
SG&A to revenue (%): 22.82043879907621
Free cash flow (dilution-adjusted): 399000000
Buyback yield (%): 0.4102227630114293
Retained earnings: -11000000
Inventory turnover: 33.25333333333333
Receivables turnover: 3.7837247405789185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.207850596576171
FCF margin (%): 5.759237875288684
Revenue growth (%): 5.641964013418725
Rule of 40 score: 11.401201888707408
Financial ratios for APG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.01
Shares outstanding: 433227989
Market cap (USD): 9535348037.890001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APG — annual report dated 2024-12-31
Total revenue: 7018000000
Gross profit: 2178000000
Operating income: 484000000
Net income: 250000000
Capital expenditures: 51000000
Operating cash flow: 620000000
Depreciation & amortization: 302000000
Net tangible assets: -1601000000
Owner earnings: 501000000
Return on net tangible assets (%): -31.292941911305434
Capex to operating income (%): 10.537190082644628
Buffett classification: The Great
Stock price: 23.98
P/E ratio: 41.555228704879994
Shares outstanding: 433227989
Book value: 2953000000
P/B ratio: 3.5180518713918048
Market cap (USD): 10388807176.22
Debt to equity: 1.027768371147985
Current ratio: 1.410079575596817
Quick ratio: 1.3342175066312998
Effective tax rate (%): 24.242424242424242
Interest coverage ratio: 3.315068493150685
COGS to revenue (%): 68.96551724137932
SG&A to revenue (%): 24.137931034482758
Free cash flow (dilution-adjusted): 504000000
Buyback yield (%): 5.775446495661226
Retained earnings: 215000000
Inventory turnover: 33.84615384615385
Receivables turnover: 3.699525566684238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.722993457794798
FCF margin (%): 7.181533200341978
Revenue growth (%): 1.2990762124711317
Rule of 40 score: 8.48060941281311
Financial ratios for APG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.98
Shares outstanding: 433227989
Market cap (USD): 10388807176.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0